4//SEC Filing
PARSHALL B LYNNE 4
Accession 0000874015-25-000176
CIK 0000874015other
Filed
Aug 7, 8:00 PM ET
Accepted
Aug 8, 6:55 PM ET
Size
7.1 KB
Accession
0000874015-25-000176
Insider Transaction Report
Form 4
PARSHALL B LYNNE
DirectorDirector, COO
Transactions
- Sale
Common Stock
2025-08-06$41.87/sh−4,600$192,595→ 86,744 total - Sale
Common Stock
2025-08-06$42.63/sh−400$17,051→ 86,344 total
Footnotes (3)
- [F1]Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 6, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.5 to $42.36 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc., any security holder of Ionis Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.56 to $42.83 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc., any security holder of Ionis Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) on this Form 4.
Documents
Issuer
IONIS PHARMACEUTICALS INC
CIK 0000874015
Entity typeother
Related Parties
1- filerCIK 0001073385
Filing Metadata
- Form type
- 4
- Filed
- Aug 7, 8:00 PM ET
- Accepted
- Aug 8, 6:55 PM ET
- Size
- 7.1 KB